探索BODIPY衍生物作为抗癌声动疗法的声敏化剂
Xudong Li1, Xianbin Sun1, Hui Chen2
1Cancer Metastasis Alert and Prevention Center, College of Chemistry, Fujian Provincial Key Laboratory of Cancer Metastasis Chemoprevention and Chemotherapy, Fuzhou University, Fuzhou, 350108, China.
European journal of medicinal chemistry
|December 15, 2023
概括
研究人员开发了用于声动疗 (SDT) 的新型二甲基 (BODIPY) 染料. 一种染料BDP4在治疗癌细胞和瘤方面表现出高效,为非侵入性癌症治疗提供了一个有前途的新途径.
科学领域:
- 生物医学工程 生物医学工程
- 材料科学 材料科学 材料科学
- 在瘤学瘤学.
背景情况:
- 声动疗 (SDT) 是一种新兴的非侵入性癌症治疗方法,具有深层组织透能力.
- 开发具有高效率和安全性的新型声敏剂对于推进SDT至关重要.
- 二甲基 (BODIPY) 染料在生物医学中广泛使用,但它们作为声敏剂的潜力仍然未被探索.
研究的目的:
- 合成和研究新的BODIPY染料,以发现它们在SDT中作为声敏剂的潜力.
- 为了评估这些新的BODIPY染料对抗癌症的声敏度和治疗效果.
- 阐明最有效的BODIPY染料的潜在声动力学治疗机制.
主要方法:
- 合成了四种新的BODIPY染料 (BDP1-BDP4).
- 在体外评估声敏度和杀死癌细胞的疗效.
- 使用携带瘤的小鼠进行体内研究,以评估治疗结果.
- 研究反应性氧物种的产生,化效应和细胞亡.
主要成果:
- BDP4表现出优越的声敏度和高SDT效率对抗癌细胞.
- 在携带瘤的小鼠体内,BDP4有效抑制了瘤生长.
- 该研究确定了反应性氧物种和化作为促进BDP4声动力学效应的关键机制.
结论:
- 这项研究介绍了BODIPY染料作为SDT的新型声敏剂.
- BDP4显示出开发用于癌症治疗的更有效,更安全的声敏化剂的巨大潜力.
- 这些发现为瘤学中基于BODIPY的治疗术开辟了新的途径.
更多相关视频
09:07Sonodynamic Therapy for the Treatment of Glioblastoma Multiforme in a Mouse Model Using a Portable Benchtop Focused Ultrasound System
Published on: February 10, 2023
2.5K
09:45Photodynamic Therapy with Blended Conducting Polymer/Fullerene Nanoparticle Photosensitizers
Published on: October 28, 2015
8.5K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K